Sign up to save your podcasts
Or
Share Cell Therapy For Corneal Endothelial Dystrophies With Aurion Biotech's Greg Kunst
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Cell Therapy For Corneal Endothelial Dystrophies With Aurion Biotech's Greg Kunst
We love to hear from our listeners. Send us a message.
For this third and final episode recorded at ARM's 2023 Meeting on the Mesa, Cell & Gene: The Podcast Host, Erin Harris, sat down with Greg Kunst, president, CEO, and Board member at Aurion Biotech. Listen in as they discuss the cell therapy used to treat corneal endothelial disease and how Greg navigated the event as a first-timer attending Meeting on the Mesa.
Subscribe to the podcast!
Apple | Spotify | YouTube
View all episodes
By Erin Harris
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
For this third and final episode recorded at ARM's 2023 Meeting on the Mesa, Cell & Gene: The Podcast Host, Erin Harris, sat down with Greg Kunst, president, CEO, and Board member at Aurion Biotech. Listen in as they discuss the cell therapy used to treat corneal endothelial disease and how Greg navigated the event as a first-timer attending Meeting on the Mesa.
Subscribe to the podcast!
Apple | Spotify | YouTube
More shows like Cell & Gene: The Podcast
View all
Nature Podcast
757 Listeners
HBR IdeaCast
177 Listeners
Planet Money
30,845 Listeners
Motley Fool Money
3,195 Listeners
Freakonomics Radio
32,291 Listeners
The Knowledge Project with Shane Parrish
2,648 Listeners
Immune
272 Listeners
The Readout Loud
318 Listeners
BioCentury This Week
29 Listeners
People I (Mostly) Admire
2,134 Listeners
Raising Health
147 Listeners
Biotech Hangout
18 Listeners
ASGCT Podcast Network
15 Listeners
NEJM AI Grand Rounds
54 Listeners
HBR On Leadership
152 Listeners